TrialNature cancer2025
Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trial.
Mehmet A Bilen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this paperpooled itcites it